Cargando…

The association between eosinophilic exacerbation and eosinophilic levels in stable COPD

BACKGROUND: Blood eosinophil count may predict treatment response in patients with chronic obstructive pulmonary disease (COPD) during acute exacerbations (AE). However, the ability and thresholds of blood eosinophil counts in stable status to predict eosinophilic AECOPD have not been completely inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Hye Seon, Kim, Sung Kyoung, Kim, Yong Hyun, Kim, Jin Woo, Lee, Sang Haak, Yoon, Hyung Kyu, Rhee, Chin Kook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923497/ https://www.ncbi.nlm.nih.gov/pubmed/33653314 http://dx.doi.org/10.1186/s12890-021-01443-4

Ejemplares similares

Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD
por: Kang, Hye Seon, et al.
Publicado: (2016)

Blood eosinophil count as a prognostic biomarker in COPD
por: Oh, Yeon-Mok, et al.
Publicado: (2018)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
por: Yoon, Jung-Ki, et al.
Publicado: (2020)

Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD
por: Celejewska-Wójcik, Natalia, et al.
Publicado: (2021)

Variability of blood eosinophil count and prognosis of COPD exacerbations
por: Martínez-Gestoso, Sandra, et al.
Publicado: (2021)

Blood Eosinophils and Exhaled Nitric Oxide: Surrogate Biomarkers of Airway Eosinophilia in Stable COPD and Exacerbation
por: Antus, Balazs, et al.
Publicado: (2022)

Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker
por: Acartürk Tunçay, Eylem, et al.
Publicado: (2017)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
por: Vogelmeier, Claus F., et al.
Publicado: (2019)

Stability in eosinophil categorisation during subsequent severe exacerbations of COPD
por: Citgez, Emanuel, et al.
Publicado: (2021)

Association of blood eosinophils and plasma periostin with FEV(1) response after 3-month inhaled corticosteroid and long-acting beta(2)-agonist treatment in stable COPD patients
por: Park, Hye Yun, et al.
Publicado: (2015)

Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients
por: Lim, Jeong Uk, et al.
Publicado: (2019)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
por: Eltboli, Osama, et al.
Publicado: (2014)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018)

Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation
por: Gong, Yaya, et al.
Publicado: (2022)

Longitudinal changes in forced expiratory volume in 1 s in patients with eosinophilic chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?
por: Saltürk, Cüneyt, et al.
Publicado: (2015)

Blood eosinophil count predicts treatment failure and hospital readmission for COPD
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study
por: Adir, Yochai, et al.
Publicado: (2018)

Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database
por: Lee, Hyun, et al.
Publicado: (2016)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study
por: Ellingsen, Jens, et al.
Publicado: (2021)

Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
por: Mayhew, David, et al.
Publicado: (2018)

Eosinophilic airway inflammation in COPD
por: Saha, Shironjit, et al.
Publicado: (2006)

Differences in hospital admissions for acute exacerbations of COPD during the COVID-19 pandemic stratified by stable-state blood eosinophil count
por: Aung, Hnin, et al.
Publicado: (2023)

In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations
por: Worth, Heinrich, et al.
Publicado: (2023)

Effects of prednisolone on eosinophils, IL-5, eosinophil cationic protein, EG2+ eosinophils, and nitric oxide metabolites in the sputum of patients with exacerbated asthma.
por: Jang, A. S., et al.
Publicado: (2000)

Natural course of early COPD
por: Rhee, Chin Kook, et al.
Publicado: (2017)

Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD
por: Negewo, Netsanet A, et al.
Publicado: (2016)

Eosinophilic myocarditis: case series and literature review
por: Sohn, Kyoung-Hee, et al.
Publicado: (2015)

A Case of Eosinophilic Fasciitis Presenting as Pitting Edema of the Lower Extremities
por: Lee, Hee Seon, et al.
Publicado: (2014)

Comparison of Korean COPD Guideline and GOLD Initiative Report in Term of Acute Exacerbation: A Validation Study for Korean COPD Guideline
por: Hwang, Yong Il, et al.
Publicado: (2014)

Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis
por: Jabarkhil, Ajmal, et al.
Publicado: (2020)

Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy
por: Benson, Victoria S, et al.
Publicado: (2019)

Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients
por: Lim, Jeong Uk, et al.
Publicado: (2018)

Eosinophilic Gastritis Presenting as Tissue Necrosis
por: Jo, Yong Min, et al.
Publicado: (2015)

Warfarin-Induced Eosinophilic Pleural Effusion
por: Jo, Yong-Min, et al.
Publicado: (2011)

348. Etiology of Eosinophilic Meningitis in Korea
por: Park, Sunghee, et al.
Publicado: (2020)

Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease
por: Kim, Kyung Hoon, et al.
Publicado: (2017)

Clinical Features of Eosinophilic Bronchitis
por: Joo, Jae Hak, et al.
Publicado: (2002)

Blood Eosinophils and Pulmonary Rehabilitation in COPD
por: Aljazeeri, Jafar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mfc3am55v5rau0hm093vtu6lg8